Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases

  • Matthieu Minty
  • Thibault Canceil
  • Matteo Serino
  • Remy Burcelin
  • François Tercé
  • Vincent Blasco-BaqueEmail author


It has recently become evident that the periodontium (gingiva, desmodontal ligament, cementum and alveolar bone) and the associated microbiota play a pivotal role in regulating human health and diseases. The oral cavity is the second largest microbiota in the body with around 500 different bacterial species identified today. When disruption of oral cavity and dysbiosis occur, the proportion of strict anaerobic Gram-negative bacteria is then increased. Patients with periodontitis present 27 to 53% more risk to develop diabetes than the control population suggesting that periodontitis is an aggravating factor in the incidence of diabetes. Moreover, dysbiosis of oral microbiota is involved in both periodontal and metabolic disorders (cardiovascular diseases, dyslipidaemia …). The oral diabetic dysbiosis is characterized by a specific bacteria Porphyromonas, which is highly expressed in periodontal diseases and could exacerbate insulin resistance. In this review, we will address the nature of the oral microbiota and how it affects systemic pathologies with a bidirectional interaction. We also propose that using prebiotics like Akkermansia muciniphila may influence oral microbiota as novel therapeutic strategies. The discovery of the implication of oral microbiota for the control of metabolic diseases could be a new way for personalized medicine.


Oral microbiota Periodontitis Metabolic diseases Dysbiosis 


Conflict of interest

The authors declare that they have no conflict of interest.

Compliance with ethical standards

Not applicable for this review.


  1. 1.
    Pischon T, Hu F, Rexrode K, Girman C, Manson J, Rimm E. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis. 2008;197:392–9.CrossRefGoogle Scholar
  2. 2.
    Firatli E. The relationship between clinical periodontal status and insulin-dependent diabetes mellitus. Results after 5 years. J Periodontol. 1997;68:136–40.CrossRefGoogle Scholar
  3. 3.
    D’Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani A, Deanfield J. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab. 2008;93:3989–94.CrossRefGoogle Scholar
  4. 4.
    Vergnes JN, Kaminski M, Lelong N, Musset AM, Sixou M, Nabet C. Maternal dental caries and pre-term birth: results from the EPIPAP study. Acta Odontol Scand. 2011.Google Scholar
  5. 5.
    Löe H. Care. D. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care. 1993;16:329–34.CrossRefGoogle Scholar
  6. 6.
    Soell M, Hassan M, Miliauskaite A, Haïkel Y, Selimovic D. The oral cavity of elderly patients in diabetes. Diabetes Metab. 2007;33(Suppl 1):S10–8.CrossRefGoogle Scholar
  7. 7.
    Slots J. Rapid identification of important periodontal microorganisms by cultivation. Oral Microbiol Immunol. 1986;1:48–57.CrossRefGoogle Scholar
  8. 8.
    Doan N, Contreras A, Flynn J, Morrison J, Slots J. Proficiencies of three anaerobic culture systems for recovering periodontal pathogenic bacteria. J Clin Microbiol. 1999;37:171–4.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Saito T, Shimazaki Y. Metabolic disorders related to obesity and periodontal disease. Periodontol. 2007;43:254–66.CrossRefGoogle Scholar
  10. 10.
    Hettne K, Weeber M, Laine M, Ten Cate H, Boyer S, Kors J. Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: lipopolysaccharide as a case study. J Clin Periodontol. 2007;34:1016–24.CrossRefGoogle Scholar
  11. 11.
    Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7.CrossRefGoogle Scholar
  12. 12.
    Shoelson S, Lee J, Goldfine A. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793–801.CrossRefGoogle Scholar
  13. 13.
    Preshaw PM, Bissett SM. Periodontitis: oral complication of diabetes. Endocrinol Metab Clin N Am. 2013;42(4):849–67. Scholar
  14. 14.
    Nanci A, Bosshardt DD. Structure of periodontal tissues in health and disease. Periodontol 2000. 2006;40:11–28. Scholar
  15. 15.
    Preshaw PM. Antibiotics in the treatment of periodontitis. Dent Update. 2004;31(8):448 -50, 53-4, 56.CrossRefGoogle Scholar
  16. 16.
    Taylor JJ, Preshaw PM. Gingival crevicular fluid and saliva. Periodontol 2000. 2016;70(1):7–10. doi: Scholar
  17. 17.
    Foster BL. On the discovery of cementum. J Periodontal Res. 2017;52(4):666–85. Scholar
  18. 18.
    de Jong T, Bakker AD, Everts V, Smit TH. The intricate anatomy of the periodontal ligament and its development: lessons for periodontal regeneration. J Periodontal Res. 2017;52(6):965–74. Scholar
  19. 19.
    Preshaw PM, Foster N, Taylor JJ. Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective. Periodontol 2000. 2007;45:138–157. doi: Scholar
  20. 20.
    Tsuboi K, Hasegawa T, Hongo H, Yurimoto H, Kobayashi S. [Bone Cell Biology Assessed by Microscopic Approach. Novel insights about bone tissue by new microscopy systems]. Clin Calcium. 2015;25(10):1505–11. doi: CliCa151015051511.Google Scholar
  21. 21.
    Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simoes MJ, Cerri PS. Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int. 2015;2015:421746. Scholar
  22. 22.
    Listgarten MA, Loomer PM. Microbial identification in the management of periodontal diseases. A systematic review. Ann Periodontol. 2003;8(1):182–92. Scholar
  23. 23.
    Field CA, Gidley MD, Preshaw PM, Jakubovics N. Investigation and quantification of key periodontal pathogens in patients with type 2 diabetes. J Periodontal Res. 2012;47(4):470–8. Scholar
  24. 24.
    Preshaw PM, Walls AW, Jakubovics NS, Moynihan PJ, Jepson NJ, Loewy Z. Association of removable partial denture use with oral and systemic health. J Dent. 2011;39(11):711–9. Scholar
  25. 25.
    Barksby HE, Lea SR, Preshaw PM, Taylor JJ. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol. 2007;149(2):217–25. Scholar
  26. 26.
    Blasco-Baque V, Garidou L, Pomie C, Escoula Q, Loubieres P, Le Gall-David S, et al. Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut. 2017;66(5):872–85. Scholar
  27. 27.
    Fak F, Tremaroli V, Bergstrom G, Backhed F. Oral microbiota in patients with atherosclerosis. Atherosclerosis. 2015;243(2):573–8. Scholar
  28. 28.
    Krishnan K, Chen T, Paster BJ. A practical guide to the oral microbiome and its relation to health and disease. Oral Dis. 2017;23(3):276–86. Scholar
  29. 29.
    Al-Shehri SS, Sweeney EL, Cowley DM, Liley HG, Ranasinghe PD, Charles BG, et al. Deep sequencing of the 16S ribosomal RNA of the neonatal oral microbiome: a comparison of breast-fed and formula-fed infants. Sci Rep. 2016;6:38309. Scholar
  30. 30.
    Feres M, Teles F, Teles R, Figueiredo LC, Faveri M. The subgingival periodontal microbiota of the aging mouth. Periodontol 2000. 2016;72(1):30–53. doi: Scholar
  31. 31.
    O'Dowd LK, Durham J, McCracken GI, Preshaw PM. Patients' experiences of the impact of periodontal disease. J Clin Periodontol. 2010;37(4):334–9. Scholar
  32. 32.
    Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313(19):1973–4. Scholar
  33. 33.
    Amiri AA, Maboudi A, Bahar A, Farokhfar A, Daneshvar F, Khoshgoeian HR, et al. Relationship between type 2 diabetic retinopathy and periodontal disease in Iranian adults. N Am J Med Sci. 2014;6(3):139–44. Scholar
  34. 34.
    LaMonte MJ, Williams AM, Genco RJ, Andrews CA, Hovey KM, Millen AE, et al. Association between metabolic syndrome and periodontal disease measures in postmenopausal women: the Buffalo OsteoPerio study. J Periodontol. 2014;85(11):1489–501. Scholar
  35. 35.
    Poplawska-Kita A, Siewko K, Szpak P, Krol B, Telejko B, Klimiuk PA, et al. Association between type 1 diabetes and periodontal health. Adv Med Sci. 2014;59(1):126–31. Scholar
  36. 36.
    Pranckeviciene A, Siudikiene J, Ostrauskas R, Machiulskiene V. Severity of periodontal disease in adult patients with diabetes mellitus in relation to the type of diabetes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(1):117–23. Scholar
  37. 37.
    Sakalauskiene J, Kubilius R, Gleiznys A, Vitkauskiene A, Ivanauskiene E, Saferis V. Relationship of clinical and microbiological variables in patients with type 1 diabetes mellitus and periodontitis. Med Sci Monit. 2014;20:1871–7. doi: Scholar
  38. 38.
    Schjetlein AL, Jorgensen ME, Lauritzen T, Pedersen ML. Periodontal status among patients with diabetes in Nuuk. Greenland Int J Circumpolar Health. 2014;73:26093. Scholar
  39. 39.
    Ahmad A, Furuta M, Shinagawa T, Takeuchi K, Takeshita T, Shimazaki Y, et al. Association of periodontal status with liver abnormalities and metabolic syndrome. J Oral Sci. 2015;57(4):335–43. Scholar
  40. 40.
    Alhabashneh R, Khader Y, Herra Z, Asa'ad F, Assad F. The association between periodontal disease and metabolic syndrome among outpatients with diabetes in Jordan. J Diabetes Metab Disord. 2015;14:67. Scholar
  41. 41.
    Iwasaki M, Sato M, Minagawa K, Manz MC, Yoshihara A, Miyazaki H. Longitudinal relationship between metabolic syndrome and periodontal disease among Japanese adults aged >/=70 years: the Niigata study. J Periodontol. 2015;86(4):491–8. Scholar
  42. 42.
    Lee KS, Lee SG, Kim EK, Jin HJ, Im SU, Lee HK, et al. Metabolic syndrome parameters in adolescents may be determinants for the future periodontal diseases. J Clin Periodontol. 2015;42(2):105–12. Scholar
  43. 43.
    Adachi K, Mishiro T, Tanaka S, Yoshikawa H, Kinoshita Y. A study on the relationship between reflux esophagitis and periodontitis. Intern Med. 2016;55(18):2523–8. Scholar
  44. 44.
    Chen X, Xie L, Liu Y, Chen D, Yu Q, Gan X, et al. Metabolic syndrome and periodontal disease among civilian pilots. Aerosp Med Hum Perform. 2016;87(12):1016–20. Scholar
  45. 45.
    Corlan Puscu D, Ciuluvica RC, Anghel A, Malaescu GD, Ciursas AN, Popa GV, et al. Periodontal disease in diabetic patients - clinical and histopathological aspects. Romanian J Morphol Embryol. 2016;57(4):1323–9.Google Scholar
  46. 46.
    Furuta M, Liu A, Shinagawa T, Takeuchi K, Takeshita T, Shimazaki Y, et al. Tooth loss and metabolic syndrome in middle-aged Japanese adults. J Clin Periodontol. 2016;43(6):482–91. Scholar
  47. 47.
    Gomes-Filho IS. das Merces MC, de Santana Passos-Soares J, Seixas da Cruz S, Teixeira Ladeia AM, Trindade SC et al. severity of periodontitis and metabolic syndrome: is there an association? J Periodontol. 2016;87(4):357–66. Scholar
  48. 48.
    Kaye EK, Chen N, Cabral HJ, Vokonas P, Garcia RI. Metabolic syndrome and periodontal disease progression in men. J Dent Res. 2016;95(7):822–8. Scholar
  49. 49.
    Morita T, Yamazaki Y, Fujiharu C, Ishii T, Seto M, Nishinoue N, et al. Association between the duration of periodontitis and increased Cardiometabolic risk factors: a 9-year cohort study. Metab Syndr Relat Disord. 2016;14(10):475–82. Scholar
  50. 50.
    Seraphim AP, Chiba FY, Pereira RF, Mattera MS, Moimaz SA, Sumida DH. Relationship among periodontal disease, insulin resistance, salivary cortisol, and stress levels during pregnancy. Braz Dent J. 2016;27(2):123–7. Scholar
  51. 51.
    Tavakoli M, Izadi M, Yaghini J, Rastegari A, Abed AM. A survey on the effects of metabolic syndrome on the periodontal indices of hemodialysis patients. Dent Res J (Isfahan). 2016;13(4):333–7.CrossRefGoogle Scholar
  52. 52.
    Alazawi W, Bernabe E, Tai D, Janicki T, Kemos P, Samsuddin S, et al. Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease. PLoS One. 2017;12(12):e0185902. Scholar
  53. 53.
    Deshpande NC, Amrutiya MR. Obesity and oral health - is there a link? An observational study. J Indian Soc Periodontol. 2017;21(3):229–33. Scholar
  54. 54.
    Drazewski D, Grzymislawska M, Korybalska K, Czepulis N, Grzymislawski M, Witowski J et al. Oral Health Status of Patients with Lysosomal Storage Diseases in Poland. Int J Environ Res Public Health. 2017;14(3). doi: Scholar
  55. 55.
    Goulart AC, Armani F, Arap AM, Nejm T, Andrade JB, Bufarah HB, et al. Relationship between periodontal disease and cardiovascular risk factors among young and middle-aged Brazilians. Cross-sectional study Sao Paulo Med J. 2017;135(3):226–33. Scholar
  56. 56.
    Jaramillo A, Contreras A, Lafaurie GI, Duque A, Ardila CM, Duarte S, et al. Association of metabolic syndrome and chronic periodontitis in Colombians. Clin Oral Investig. 2017;21(5):1537–44. Scholar
  57. 57.
    Kikui M, Kokubo Y, Ono T, Kida M, Kosaka T, Yamamoto M, et al. Relationship between metabolic syndrome components and periodontal disease in a Japanese general population: the Suita study. J Atheroscler Thromb. 2017;24(5):495–507. Scholar
  58. 58.
    Kitagawa M, Kurahashi T, Matsukubo T. Relationship between general health, lifestyle, Oral health, and periodontal disease in adults: a large cross-sectional study in Japan. Bull Tokyo Dent Coll. 2017;58(1):1–8. Scholar
  59. 59.
    Musskopf ML, Daudt LD, Weidlich P, Gerchman F, Gross JL, Oppermann RV. Metabolic syndrome as a risk indicator for periodontal disease and tooth loss. Clin Oral Investig. 2017;21(2):675–83. Scholar
  60. 60.
    Popescu D, Gheorghe D, Puiu I, Rica AM. Odontal-Periodontal Changes in Patients with Type 1 Diabetes. Curr Health Sci J. 2017;43(4):330–4. doi:
  61. 61.
    Sadeghi R, Taleghani F, Mohammadi S, Zohri Z. The effect of diabetes mellitus type I on periodontal and dental status. J Clin Diagn Res. 2017;11(7):ZC14–ZC7. Scholar
  62. 62.
    Sfasciotti GL, Marini R, Pacifici A, Ierardo G, Pacifici L, Polimeni A. Childhood overweight-obesity and periodontal diseases: is there a real correlation? Ann Stomatol (Roma). 2016;7(3):65–72. doi:
  63. 63.
    Song SJ, Lee SS, Han K, Park JB. Periodontitis is associated with diabetic retinopathy in non-obese adults. Endocrine. 2017;56(1):82–9. Scholar
  64. 64.
    Vallogini G, Nobili V, Rongo R, De Rosa S, Magliarditi F, D'Anto V et al. Evaluation of the relationship between obesity, dental caries and periodontal disease in adolescents. Eur J Paediatr Dent. 2017;18(4):268–72. doi:
  65. 65.
    Coelho A, Carneiro AS, Pereira VF, Paula AP, Macedo AP, Carrilho EVP. Oral Health of Portuguese Children with Type 1 Diabetes: A Multiparametric Evaluation. J Clin Pediatr Dent. 2018;42(3):231–5. doi: Scholar
  66. 66.
    Dhir S, Kumar V. Are cardiovascular risk parameters and glycemic levels associated with periodontitis in type 2 diabetes patients? A clinical study. Indian Heart J. 2018;70(3):430–2. Scholar
  67. 67.
    Diaz Rosas CY, Cardenas Vargas E, Castaneda-Delgado JE, Aguilera-Galaviz LA, Aceves Medina MC. Dental, periodontal and salivary conditions in diabetic children associated with metabolic control variables and nutritional plan adherence. Eur J Paediatr Dent. 2018;19(2):119–26. doi:
  68. 68.
    Kemer Dogan ES, Kirzioglu FY, Dogan B, Fentoglu O, Kale B. The effect of menopause on the relationship between hyperlipidemia and periodontal disease via salivary 8-hydroxy-2′-deoxyguanosine and myeloperoxidase levels. Acta Odontol Scand. 2018;76(2):92–7. Scholar
  69. 69.
    Kim OS, Shin MH, Kweon SS, Lee YH, Kim OJ, Kim YJ, et al. The severity of periodontitis and metabolic syndrome in Korean population: the dong-gu study. J Periodontal Res. 2018;53(3):362–8. Scholar
  70. 70.
    Koo HS, Hong SM. Prevalence and risk factors for periodontitis among patients with metabolic syndrome. Metab Syndr Relat Disord. 2018;16(7):375–81. Scholar
  71. 71.
    Nascimento GG, Leite FRM, Peres KG, Demarco FF, Correa MB, Peres MA. Metabolic syndrome and periodontitis: a structural equation modeling approach. J Periodontol. 2019;90(6):655–62. Scholar
  72. 72.
    Nibali L, Donos N, Terranova V, Di Pino A, Di Marca S, Ferrara V, et al. Left ventricular geometry and periodontitis in patients with the metabolic syndrome. Clin Oral Investig. 2019;23(6):2695–703. Scholar
  73. 73.
    Pham T. The association between periodontal disease severity and metabolic syndrome in Vietnamese patients. Int J Dent Hyg. 2018;16(4):484–91. Scholar
  74. 74.
    Helenius-Hietala J, Suominen AL, Ruokonen H, Knuuttila M, Puukka P, Jula A, et al. Periodontitis is associated with incident chronic liver disease-a population-based cohort study. Liver Int. 2019;39(3):583–91. Scholar
  75. 75.
    Sakurai SI, Yamada SI, Karasawa I, Sakurai A, Kurita H. A longitudinal study on the relationship between dental health and metabolic syndrome in Japan. J Periodontol. 2019;90(7):728–46. Scholar
  76. 76.
    Zhao D, Zhen Z, Pelekos G, Yiu KH, Jin L. Periodontal disease increases the risk for onset of systemic comorbidities in dental hospital attendees: an 18-year retrospective cohort study. J Periodontol. 2019;90(3):225–33. Scholar
  77. 77.
    Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol. 2012;12:16. Scholar
  78. 78.
    Lamster IB, Pagan M. Periodontal disease and the metabolic syndrome. Int Dent J. 2017;67(2):67–77. Scholar
  79. 79.
    Nitta H, Katagiri S, Nagasawa T, Izumi Y, Ishikawa I, Izumiyama H, et al. The number of microvascular complications is associated with an increased risk for severity of periodontitis in type 2 diabetes patients: results of a multicenter hospital-based cross-sectional study. J Diabetes Investig. 2017;8(5):677–86. Scholar
  80. 80.
    Albandar JM, Rams TE. Global epidemiology of periodontal diseases: an overview. Periodontology 2000. 2002;29:7–10.CrossRefGoogle Scholar
  81. 81.
    D'Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, et al. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab. 2008;93(10):3989–94. Scholar
  82. 82.
    Vergnes JN. Treating periodontal disease may improve metabolic control in diabetics. Evidence-based dentistry. 2010;11(3):73–4. Scholar
  83. 83.
    Borrell LN, Kunzel C, Lamster I, Lalla E. Diabetes in the dental office: using NHANES III to estimate the probability of undiagnosed disease. J Periodontal Res. 2007;42(6):559–65. Scholar
  84. 84.
    Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol. 2011;48(4):257–73. Scholar
  85. 85.
    Blasco-Baque V, Kemoun P, Loubieres P, Arnal JF, Gourdy P, Serino M, et al. Impact of type 2 diabetes on the development of periodontal disease in the mouse. Bull Group Int Rech Sci Stomatol Odontol. 2011;50(2):11–2.PubMedGoogle Scholar
  86. 86.
    Nicolas S, Blasco-Baque V, Fournel A, Gilleron J, Klopp P, Waget A et al. Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism. Mol Syst Biol. 2017;13(3):921. doi: Scholar
  87. 87.
    Veitenhansl M, Stegner K, Hierl FX, Dieterle C, Feldmeier H, Gutt B, et al. 40th EASD annual meeting of the European Association for the Study of diabetes : Munich, Germany, 5-9 September 2004. Diabetologia. 2004;47(Suppl 1):A1–A464. Scholar
  88. 88.
    Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr. 2008;87(5):1219–23.CrossRefGoogle Scholar
  89. 89.
    Courbon G, Rinaudo-Gaujous M, Blasco-Baque V, Auger I, Caire R, Mijola L, et al. Porphyromonas gingivalis experimentally induces periodontis and an anti-CCP2-associated arthritis in the rat. Ann Rheum Dis. 2019. Scholar
  90. 90.
    Amano A. Disruption of epithelial barrier and impairment of cellular function by Porphyromonas gingivalis. Front Biosci. 2007;12:3965–74.CrossRefGoogle Scholar
  91. 91.
    Burcelin R, Garidou L, Pomie C. Immuno-microbiota cross and talk: the new paradigm of metabolic diseases. Semin Immunol. 2012;24(1):67–74. Scholar
  92. 92.
    Burcelin R. Gut microbiota and immune crosstalk in metabolic disease. Mol Metab. 2016;5(9):771–81. Scholar
  93. 93.
    Koren O, Spor A, Felin J, Fak F, Stombaugh J, Tremaroli V, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4592–8. Scholar
  94. 94.
    Darré L, Vergnes J-N, Gourdy P, Sixou M. Efficacy of periodontal treatment on glycaemic control in diabetic patients: a meta-analysis of interventional studies. Diabetes Metab. 2008;34:497–506.CrossRefGoogle Scholar
  95. 95.
    Grossi S. Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol. 2001;6:138–45.CrossRefGoogle Scholar
  96. 96.
    Miller L, Manwell M, Newbold D, Reding M, Rasheed A, Blodgett J. The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases. J Periodontol. 1992;63:843–8.CrossRefGoogle Scholar
  97. 97.
    Vergnes JN, Canceill T, Vinel A, Laurencin-Dalicieux S, Maupas-Schwalm F, Blasco-Baque V, et al. The effects of periodontal treatment on diabetic patients: the DIAPERIO randomized controlled trial. J Clin Periodontol. 2018. Scholar
  98. 98.
    Rosier BT, Marsh PD, Mira A. Resilience of the Oral microbiota in health: mechanisms that prevent Dysbiosis. J Dent Res. 2018;97(4):371–80. Scholar
  99. 99.
    Fang D, Shi D, Lv L, Gu S, Wu W, Chen Y, et al. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota. Sci Rep. 2017;7(1):8770. Scholar
  100. 100.
    Wang L, Wu Y, Zhuang L, Chen X, Min H, Song S, et al. Puerarin prevents high-fat diet-induced obesity by enriching Akkermansia muciniphila in the gut microbiota of mice. PLoS One. 2019;14(6):e0218490. Scholar
  101. 101.
    Schneeberger M, Everard A, Gomez-Valades AG, Matamoros S, Ramirez S, Delzenne NM, et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep. 2015;5:16643. Scholar
  102. 102.
    Moya-Perez A, Neef A, Sanz Y. Bifidobacterium pseudocatenulatum CECT 7765 reduces obesity-associated inflammation by restoring the lymphocyte-macrophage balance and gut microbiota structure in high-fat diet-fed mice. PLoS One. 2015;10(7):e0126976. Scholar
  103. 103.
    Berridge MJ. Vitamin D deficiency and diabetes. Biochem J 2017;474(8):1321–1332. doi: Scholar
  104. 104.
    Cai T, Yang ZY, Nie L, Zhen JX, Deng L, Zhou Z. Association between vitamin D receptor BsmI gene polymorphism and periodontitis: a meta-analysis in a single ethnic group. Cell Mol Biol (Noisy-le-grand). 2017;63(11):1–4. doi: Scholar
  105. 105.
    Ratheesh V, Subramanian S, Prakash PSG, Victor DJ. Evaluation of Association of Vitamin D Receptor Genetic Polymorphism with severe chronic periodontitis in an ethnic Tamilian population. Genet Test Mol Biomarkers. 2018;22(10):615–21. Scholar
  106. 106.
    Murthykumar K, Arjunkumar R, Jayaseelan VP. Association of vitamin D receptor gene polymorphism (rs10735810) and chronic periodontitis. J Investig Clin Dent. 2019:e12440. doi:
  107. 107.
    Zhu A, Chen J, Wu P, Luo M, Zeng Y, Liu Y, et al. Cationic polystyrene resolves nonalcoholic Steatohepatitis, obesity, and metabolic disorders by promoting Eubiosis of gut microbiota and decreasing Endotoxemia. Diabetes. 2017;66(8):2137–43. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Matthieu Minty
    • 1
    • 2
    • 3
  • Thibault Canceil
    • 2
    • 3
  • Matteo Serino
    • 4
  • Remy Burcelin
    • 1
    • 2
    • 3
  • François Tercé
    • 1
    • 2
    • 3
  • Vincent Blasco-Baque
    • 1
    • 2
    • 3
    • 5
    Email author
  1. 1.INSERM U1048, F-31432 Toulouse, FranceInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC)ToulouseFrance
  2. 2.Université Paul Sabatier III (UPS)ToulouseFrance
  3. 3.CHU Toulouse, Service d’Odontologie ToulouseToulouseFrance
  4. 4.INSERM, INRA, ENVT, UPSIRSD, Université de ToulouseToulouseFrance
  5. 5.INSERM UMR1048-I2MC Team 2 « Intestinal Risk Factors, Diabetes and Dyslipidemia » Building L41st floor, Hospital of Rangueil 1Toulouse Cedex 4 LabFrance

Personalised recommendations